Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine GliomaMichaël H. Meel, Esther Hulleman, Ángel M. Carcaboso et al.|Clinical Cancer Research|2020Cited by 63
Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatinDennis S. Metselaar, Esther Hulleman|EBioMedicine|2019Cited by 32
AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline gliomaDennis S. Metselaar, Esther Hulleman|iScience|2022Cited by 26
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumorsDennis S. Metselaar, Esther Hulleman|Cell Reports Medicine|2024Cited by 8
Supplementary table S1 from Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine GliomaMichaël H. Meel, Esther Hulleman, Mark C. de Gooijer et al.|Unknown|2023Cited by 0